Get the weekly note

Data as of Sep 12, 2026. Both funds on the fields they both publish, from the same sources.

ETFIQetfiq.com · independent ETF data

VTEB vs XBI: how they differ

VTEB and XBI hold 0% of their weight in the same names, and XBI returned more over the year.

Vanguard Tax-Exempt Bond Index Fund and State Street(R) SPDR(R) S&P(R) Biotech ETF.

What they hold in common

By the books each fund has filed, VTEB and XBI hold 0% of their money in the same securities at the same weight.

Largest positions each one holds and the other does not
Only in VTEBOnly in XBI
University of California 0.12%Apogee Therapeutics Inc 1.49%
Triborough Bridge & Tunnel Authority 0.12%Moderna Inc 1.41%
Colorado State Education Loan Program 0.11%Twist Bioscience Corp 1.41%
State of California 0.11%Oruka Therapeutics Inc 1.38%
New York City Transitional Finance Autho 0.09%Kymera Therapeutics Inc 1.36%
Dallas Independent School District 0.09%Viking Therapeutics Inc 1.31%
New York State Dormitory Authority 0.09%Praxis Precision Medicines Inc 1.29%
Ohio Water Development Authority Water P 0.09%Erasca Inc 1.27%

Weight overlap is an ETFIQ calculation: for every security both funds hold, the smaller of the two weights, summed. Above 50%, holding both is close to holding one of them twice. Holdings dated Apr 30, 2026 and Jun 30, 2026.

VTEB and XBI on the fields both publish, as of Sep 12, 2026. Source: ETFIQ.
VTEB
Vanguard Tax-Exempt Bond Index Fund
XBI
State Street(R) SPDR(R) S&P(R) Biotech ETF
Where it sitsCore index fundCore index fund
IssuerVanguardState Street
What it isTax-Exempt BondSPDR S&P Biotech
Total return, 1 year+0.2%+64.0%
S&P 500 over the same days+17.5%+17.5%
Gap to the S&P 500−17.3 pts+46.5 pts
Expense ratio0.03%0.35%
Holdings10185150

VTEB in plain words

VTEB is a bond fund tracking the Tax-Exempt Bond. Over the year to Sep 11, 2026 it returned +0.2% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.03% a year. It sat 3.6% below its high of Jul 6, 2026 on Sep 11, 2026.

XBI in plain words

XBI is an index equity fund tracking the SPDR S&P Biotech. Over the year to Sep 11, 2026 it returned +64.0% with distributions reinvested, against +17.5% for the S&P 500 and +23.0% for the Nasdaq-100. The prospectus expense ratio is 0.35% a year. By its holdings filed for Jun 30, 2026, 8% of the fund by weight is stocks the S&P 500 also holds, across 150 positions, with the top ten at 13.3%. It sat 9.6% below its high of Feb 8, 2021 on Sep 11, 2026.

Questions people ask

Which returned more over the last year, VTEB or XBI?
In the year to Sep 12, 2026, with distributions reinvested, VTEB returned +0.2% and XBI returned +64.0%, so XBI returned more. One year is one year; the longer windows are in the table.
Which is cheaper, VTEB or XBI?
VTEB charges 0.03% a year and XBI charges 0.35%, so VTEB is cheaper. Fees come from each fund's prospectus.

Other comparisons

Where to next

Where these figures came from

ETFIQ links to the documents behind every figure. It is not affiliated with any issuer, and a link is not an endorsement.

VTEB against XBI, ETFIQ, data as of Sep 12, 2026. Every figure is arithmetic on a named public source; the method is at etfiq.com/methodology. A comparison is not a recommendation.

Cite this page. ETFIQ, VTEB against XBI, data as of Sep 12, 2026. https://etfiq.com/compare/any/VTEB-XBI Free to use with attribution; the underlying files are at Open data.

A comparison is not a recommendation. Standards and sources